CIK 0001595097
- Non-accelerated filer
- Smaller reporting company
Corbus Pharmaceuticals Holdings, Inc.
Sign in to watch- Ticker
- CRBP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464348039
- Phone
- +1 617-963-0103
- Business address
- 500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
- Former names
- SAV Acquisition Corp
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $1.56 ($1,559)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $1.61 ($1,611)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $1.67 ($1,670)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $1.68 ($1,682)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $1.69 ($1,689)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $1.72 ($1,720)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $1.79 ($1,790)
- 4 Open-market buy Chief Financial Officer bought 1,500 shares at $1.78 ($2,670)
- 4 Open-market buy Chief Executive Officer bought 535 shares at $1.76 ($941)
- 4 Open-market buy Chief Medical Officer bought 4,000 shares at $1.67 ($6,680)
- 4 Open-market buy Chief Financial Officer bought 1,500 shares at $1.70 ($2,548)
- 4 Open-market buy Chief Medical Officer bought 700 shares at $1.68 ($1,176)
- 4 Open-market buy Chief Financial Officer bought 1,500 shares at $1.71 ($2,565)
- 4 Open-market buy Chief Financial Officer bought 1,500 shares at $1.72 ($2,583)
- 4 Gift Former 10% Holder gave 375 shares (gift)
- 4 Open-market buy Chief Executive Officer bought 850 shares at $1.73 ($1,471)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at $1.69 ($3,372)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $2.12 ($10,605)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $2.14 ($10,720)
- 4 Open-market buy Chief Financial Officer bought 5,000 shares at $1.96 ($9,820)
Page 14 of 17 · 340 filings